BEST1 rs61754394: Understanding This Rare Genetic Variant

What each genotype means

What is the rs61754394 Variant?

The rs61754394 variant is a specific change in the DNA sequence of the BEST1 gene, often referred to as a missense mutation. In this case, the change results in an amino acid substitution known as p.Ala146Thr. This variant is located within the coding region of the gene, meaning it alters the blueprint used to construct the bestrophin-1 protein. Because the protein's structure is critical for its function in the eye, even small changes at the molecular level can have significant biological consequences. Geneticists track this variant using its rsID (reference SNP cluster ID) to ensure consistency in research and clinical reporting across global databases.

The Role of the BEST1 Gene

The BEST1 gene encodes a protein called bestrophin-1, which is primarily expressed in the retinal pigment epithelium (RPE). The RPE is a layer of cells that supports the light-sensitive photoreceptors in the retina. Bestrophin-1 functions as a chloride channel, helping to regulate the movement of ions and fluid across the cell membrane. This regulation is vital for maintaining the proper environment for photoreceptor survival and function. When the BEST1 gene is mutated, the resulting protein may not function correctly, leading to the accumulation of fluid or debris under the retina. This disruption is the hallmark of a group of eye disorders collectively known as bestrophinopathies.

Research and Clinical Associations

Research links the rs61754394 variant to Best vitelliform macular dystrophy (BVMD), an inherited condition characterized by the formation of yellow, egg-yolk-like lesions in the macula. The evidence for this association is categorized as limited, meaning that while clinical reports exist, the full spectrum of its impact is still being studied. BVMD is typically inherited in an autosomal dominant pattern, meaning a single copy of the variant is sufficient to influence the phenotype. However, the severity of vision loss can vary significantly between individuals, even those within the same family. Because this is a rare variant, ongoing clinical studies and case reports are essential to better understand how this specific mutation affects long-term visual outcomes.

Population Frequency

The rs61754394 variant is extremely rare across all major continental populations. According to data from the Genome Aggregation Database (gnomAD), the allele frequency is well below 0.0001. This rarity is consistent with its classification as a pathogenic variant for a specific, relatively uncommon genetic eye disorder. Because it is so infrequent in the general population, it is not typically included in standard carrier screening panels unless there is a specific clinical suspicion of a bestrophinopathy based on family history or ophthalmic examination findings.

What This Information Means for You

If you have received information about this variant, it is important to understand that genetic data is only one piece of a complex health puzzle. This variant is associated with a specific eye condition, but its presence does not guarantee that an individual will experience severe vision loss or follow a specific disease trajectory. Genetic testing results should always be interpreted by a qualified medical professional, such as a genetic counselor or an ophthalmologist specializing in retinal dystrophies. They can correlate genetic findings with clinical exams, such as electro-oculograms (EOG) or retinal imaging, to provide an accurate assessment. Never use genetic information to make independent medical decisions; always discuss your results and any concerns about your vision with your healthcare provider.

Frequently asked questions

Sources & further reading

Related variants in BEST1